Virtus ETF Advisers’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-37,909
Closed -$122K 446
2022
Q1
$122K Sell
37,909
-2,252
-6% -$7.61K 0.05% 265
2021
Q4
$173K Buy
40,161
+15,182
+61% +$82.1K 0.07% 268
2021
Q3
$149K Sell
24,979
-1,306
-5% -$8.75K 0.07% 343
2021
Q2
$218K Buy
26,285
+3,049
+13% +$24.8K 0.09% 281
2021
Q1
$200K Buy
23,236
+402
+2% +$4.46K 0.08% 329
2020
Q4
$277K Buy
22,834
+685
+3% +$9.45K 0.12% 255
2020
Q3
$360K Sell
22,149
-3,027
-12% -$49.6K 0.19% 183
2020
Q2
$378K Buy
+25,176
New +$340K 0.18% 222

Other funds holding CGEN

Virtus ETF Advisers's CGEN Position: Q2 2022 in Review

Virtus ETF Advisers sold out of Compugen (CGEN) in Q2 2022, closing a stake of 37,909 shares — an estimated $122K sold.

Virtus ETF Advisers first reported a position in CGEN in Q2 2020 and held it in 8 quarters. The position peaked at $378K in Q2 2020. 89 funds tracked by Wall St. Rank hold CGEN as of Q2 2022.

  • Virtus ETF Advisers reported no remaining Compugen position as of Q2 2022 after selling out during the quarter.
  • Virtus ETF Advisers sold 37,909 Compugen shares in Q2 2022, an estimated $122K.
  • Virtus ETF Advisers first reported a position in Compugen in Q2 2020 and held it in 8 quarters.
  • Virtus ETF Advisers's Compugen position peaked at $378K in Q2 2020.
  • 89 funds tracked by Wall St. Rank held Compugen as of Q2 2022.

Based on Virtus ETF Advisers's 13F filing for Q2 2022, filed 12 Aug 2022.